Consulta’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $156M | Buy |
+400,000
| New | +$169M | 5.63% | 10 |
|
|
2025
Q4 | – | Sell |
-150,000
| Closed | -$63.9M | – | 15 |
|
|
2025
Q3 | $63.9M | Sell |
150,000
-100,000
| -40% | -$38.8M | 3.63% | 11 |
|
|
2025
Q2 | $95.8M | Sell |
250,000
-350,000
| -58% | -$126M | 6.12% | 7 |
|
|
2025
Q1 | $207M | Buy |
600,000
+50,000
| +9% | +$16.1M | 14.02% | 3 |
|
|
2024
Q4 | $165M | Buy |
550,000
+275,000
| +100% | +$96.1M | 10.81% | 4 |
|
|
2024
Q3 | $112M | Sell |
275,000
-50,000
| -15% | -$18.3M | 6.9% | 7 |
|
|
2024
Q2 | $104M | Sell |
325,000
-75,000
| -19% | -$24.4M | 7.11% | 6 |
|
|
2024
Q1 | $133M | Sell |
400,000
-100,000
| -20% | -$30.6M | 8.59% | 3 |
|
|
2023
Q4 | $135M | Buy |
500,000
+150,000
| +43% | +$37.1M | 8.91% | 4 |
|
|
2023
Q3 | $86.1M | Buy |
350,000
+75,000
| +27% | +$20.5M | 6.19% | 9 |
|
|
2023
Q2 | $83.5M | Sell |
275,000
-75,000
| -21% | -$20.9M | 5.8% | 11 |
|
|
2023
Q1 | $92.3M | Sell |
350,000
-175,000
| -33% | -$44.5M | 7.27% | 7 |
|
|
2022
Q4 | $126M | Sell |
525,000
-225,000
| -30% | -$50.4M | 10.81% | 4 |
|
|
2022
Q3 | $138M | Buy |
750,000
+125,000
| +20% | +$24.9M | 13.78% | 1 |
|
|
2022
Q2 | $105M | Buy |
625,000
+175,000
| +39% | +$37.6M | 6.85% | 9 |
|
|
2022
Q1 | $113M | Sell |
450,000
-250,000
| -36% | -$62.8M | 5.66% | 9 |
|
|
2021
Q4 | $180M | Sell |
700,000
-165,000
| -19% | -$40.4M | 8.88% | 5 |
|
|
2021
Q3 | $210M | Sell |
865,000
-60,000
| -6% | -$14.7M | 10.46% | 6 |
|
|
2021
Q2 | $191M | Sell |
925,000
-275,000
| -23% | -$56M | 9.01% | 6 |
|
|
2021
Q1 | $226M | Sell |
1,200,000
-300,000
| -20% | -$52.9M | 11.64% | 5 |
|
|
2020
Q4 | $247M | Sell |
1,500,000
-175,000
| -10% | -$25.6M | 13.38% | 3 |
|
|
2020
Q3 | $209M | Buy |
1,675,000
+75,000
| +5% | +$9.28M | 13.99% | 2 |
|
|
2020
Q2 | $155M | Buy |
1,600,000
+100,000
| +7% | +$10.4M | 11.73% | 2 |
|
|
2020
Q1 | $135M | Buy |
1,500,000
+1,050,000
| +233% | +$136M | 11.1% | 4 |
|
|
2019
Q4 | $66.5M | Buy |
450,000
+200,000
| +80% | +$26.9M | 5.55% | 8 |
|
|
2019
Q3 | $30.1M | Hold |
250,000
| – | – | 2.59% | 12 |
|
|
2019
Q2 | $33.8M | Hold |
250,000
| – | – | 2.97% | 11 |
|
|
2019
Q1 | $32.6M | Sell |
250,000
-400,000
| -62% | -$53.7M | 3.23% | 10 |
|
|
2018
Q4 | $80.9M | Sell |
650,000
-100,000
| -13% | -$13.4M | 7.98% | 4 |
|
|
2018
Q3 | $104M | Sell |
750,000
-750,000
| -50% | -$93.4M | 9.77% | 3 |
|
|
2018
Q2 | $154M | Hold |
1,500,000
| – | – | 15.31% | 2 |
|
|
2018
Q1 | $146M | Hold |
1,500,000
| – | – | 14.79% | 3 |
|
|
2017
Q4 | $132M | Hold |
1,500,000
| – | – | 15.56% | 3 |
|
|
2017
Q3 | $119M | Buy |
1,500,000
+100,000
| +7% | +$8.04M | 15.98% | 3 |
|
|
2017
Q2 | $122M | Buy |
1,400,000
+275,000
| +24% | +$23.3M | 14.86% | 2 |
|
|
2017
Q1 | $100M | Sell |
1,125,000
-125,000
| -10% | -$10.4M | 12.11% | 3 |
|
|
2016
Q4 | $92.5M | Sell |
1,250,000
-170,000
| -12% | -$12.7M | 11.79% | 3 |
|
|
2016
Q3 | $107M | Buy |
1,420,000
+70,000
| +5% | +$5.36M | 14.03% | 1 |
|
|
2016
Q2 | $104M | Hold |
1,350,000
| – | – | 13.18% | 2 |
|
|
2016
Q1 | $105M | Buy |
1,350,000
+150,000
| +13% | +$10.5M | 12.88% | 2 |
|
|
2015
Q4 | $81.2M | Buy |
1,200,000
+200,000
| +20% | +$14M | 10.62% | 5 |
|
|
2015
Q3 | $77.4M | Buy |
+1,000,000
| New | +$88.5M | 8.17% | 7 |
|
|
2014
Q3 | – | Sell |
-1,087,996
| Closed | -$61.3M | – | 14 |
|
|
2014
Q2 | $61.3M | Buy |
+1,087,996
| New | +$57.4M | 5.72% | 10 |
|
Other funds holding HCA
Consulta's HCA Position: Q2 2026 in Review
Consulta opened a new position in HCA Healthcare (HCA) in Q2 2026: 400,000 shares worth $156M. The stake represents 5.63% of the portfolio and ranks #10 among its holdings. This is a return to the name: Consulta previously reported a position in HCA as recently as Q3 2025.
Consulta first reported a position in HCA in Q2 2014 and has held it in 43 quarters since. The position peaked at $247M in Q4 2020. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Consulta held 400,000 shares of HCA Healthcare worth $156M as of Q2 2026.
- HCA Healthcare was a new Consulta position in Q2 2026.
- HCA Healthcare made up 5.63% of Consulta's portfolio in Q2 2026, its #10 holding.
- Consulta first reported a position in HCA Healthcare in Q2 2014 and has held it in 43 quarters since.
- Consulta's HCA Healthcare position peaked at $247M in Q4 2020.
- 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Consulta's 13F filing for Q2 2026, filed 14 Aug 2026.